WASHINGTON — The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag.at $1,390, but Americans can still access the pills at no cost -- for now. The less commonly used COVID-19 treatment Lagevrio, manufactured by Merck, also will hit the market next week.
Under a new agreement, reached last month between Pfizer and the federal government, people on Medicaid, Medicare or those who are without medical insurance will not pay any out-of-pocket costs for the treatment through the end of next year. Pfizer will also offer copay assistance for the treatment through 2028. The Department of Veterans Affairs, the Department of Defense and Indian Health Service will still be able to access Paxlovid the government has on hand.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
COVID-19 treatments to enter the market with a hefty price tagPfizer said it is increasing the price of the drug.
Baca lebih lajut »
COVID-19 treatments to enter the market with a hefty price tagPfizer said it is increasing the price of the drug.
Baca lebih lajut »
COVID-19 treatments to enter the market with a hefty price tagPfizer said it is increasing the price of the drug.
Baca lebih lajut »